The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent

Catheterization and Cardiovascular Interventions

Volumn 87, Issue 2, 2016, Pages 253-261

  Belardi, Jorge ^a   Manoharan, Ganesh ^b   Albertal, Mariano ^a   Widimský, Petr ^c   Neumann, Franz Joseph ^d   Silber, Sigmund ^e   Leon, Martin B ^f   Saito, Shigeru ^g  

^a INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^e Heart Centre at Isar   (Germany)

^f NewYork Presbyterian Hospital   (United States)

^g SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

aged; drug eluting stents; hemorrhage; myocardial infarction; percutaneous coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; ZOTAROLIMUS ELUTING CORONARY STENT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CORONARY ARTERY DISEASE; DEVICES; DRUG ELUTING STENT; HEMORRHAGE; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

CARDIOVASCULAR AGENT; RAPAMYCIN; ZOTAROLIMUS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; OBSERVATIONAL STUDIES AS TOPIC; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959482474     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25334     Document Type: Article

References (22)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB,. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125: e2-e220.
2. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ,. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation 2011; 123: 933-944.
3. Alexander KP, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Foody JM, Boden WE, Smith SC Jr, Gibler WB, Ohman EM, Peterson ED,; CRUSADE Investigators. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46: 1479-1487.
4. Rathore SS, Mehta RH, Wang Y, Radford MJ, Krumholz HM,. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 2003; 114: 307-315.
5. Tran CT, Laupacis A, Mamdani MM, Tu JV,. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Am Heart J 2004; 148: 834-841.
6. Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA,. Examining the evidence: A systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 2011; 26: 783-790.
7. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH, Jacobs AK, Anderson JL, Albert N, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson W, Yancy CW,. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2012; 79: 453-495.
8. Mauri L, Leon MB, Yeung AC, Negoita M, Keyes MJ, Massaro JM,. Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). Am Heart J 2011; 161: 807-814.
9. Meredith IT, Worthley S, Whitbourn R, Walters DL, McClean D, Horrigan M, Popma JJ, Cutlip DE, DePaoli A, Negoita M, Fitzgerald PJ, RESOLUTE Investigators,. Clinical and angiographic results with the next-generation Resolute stent system: A prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv 2009; 2: 977-985.
10. Meredith IT, Worthley SG, Whitbourn R, Walters D, McClean D, Ormiston J, Horrigan M, Wilkins GT, Hendriks R, Matsis P, Muller D, Cutlip DE,. Long-term clinical outcomes with the next-generation Resolute stent system: A report of the two-year follow-up from the RESOLUTE clinical trial. Eurointervention 2010; 5: 692-697.
11. Neumann FJ, Widimsky P, Belardi JA,. One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry. Eurointervention 2012; 7: 1181-1188.
12. Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S,. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010; 363: 136-146.
13. Silber S, Windecker S, Vranckx P, Serruys PW,; RESOLUTE All Comers investigators. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet 2011; 377: 1241-1247.
14. Yeung AC, Leon MB, Jain A, Tolleson TR, Spriggs DJ, Mc Laurin BT, Popma JJ, Fitzgerald PJ, Cutlip DE, Massaro JM, Mauri L,; RESOLUTE US Investigators. Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: The RESOLUTE US clinical trial. J Am Coll Cardiol 2011; 57: 1778-1783.
15. D'Agostino RB Jr,. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281.
16. Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, Haque G, Dai D, Kong DF, Hammill B, Curtis L, Matchar D, Brindis R, Peterson ED,. Clinical effectiveness of coronary stents in elderly persons: Results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol 2009; 53: 1629-1641.
17. Groeneveld PW, Matta MA, Greenhut AP, Yang F,. Drug-eluting compared with bare-metal coronary stents among elderly patients. J Am Coll Cardiol 2008; 51: 2017-2024.
18. Fleming LM, Novack V, Novack L, Cohen SA, Negoita M, Cutlip DE,. Frequency and impact of bleeding in elective coronary stent clinical trials-Utility of three commonly used definitions. Catheter Cardiovasc Interv 2012; 80: E23-E29.
19. Ko DT, Yun L, Wijeysundera HC, Jackevicius CA, Rao SV, Austin PC, Marquis JF, Tu JV,. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years. Circ Cardiovasc Interv 2010; 3: 140-147.
20. Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ,. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Catheter Cardiovasc Interv 2012; 80: 395-405.
21. Romaguera R, Wakabayashi K, Laynez-Carnicero A, Sardi G, Maluenda G, Ben-Dor I, Torguson R, Kent KM, Satler LF, Suddath WO, Lindsay J, Pichard AD, Waksman R,. Association between bleeding severity and long-term mortality in patients experiencing vascular complications after percutaneous coronary intervention. Am J Cardiol 2012; 109: 75-81.
22. Vasaiwala S, Forman DE, Mauri L,. Drug-eluting stents in the elderly. Curr Treat Options Cardiovasc Med 2010; 12: 76-83.